Meditation Mobile App Developed for Patients With and Survivors of Cancer: Feasibility Randomized Controlled Trial
BackgroundTo address the unmet need for a commercial cancer-specific meditation app, we leveraged a long-standing partnership with a consumer-based app (ie, Calm) to develop the first commercial meditation app prototype adapted specifically for the needs of patients with canc...
Main Authors: | Jennifer Huberty, Nishat Bhuiyan, Megan Puzia, Lynda Joeman, Linda Larkey, Ruben Mesa |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2022-11-01
|
Series: | JMIR Cancer |
Online Access: | https://cancer.jmir.org/2022/4/e39228 |
Similar Items
-
Leveraging a Consumer-Based Product to Develop a Cancer-Specific Mobile Meditation App: Prototype Development Study
by: Jennifer Huberty, et al.
Published: (2022-01-01) -
A Novel Educational Control Group Mobile App for Meditation Interventions: Single-Group Feasibility Trial
by: Huberty, Jennifer, et al.
Published: (2020-07-01) -
A Mobile App for Stress Management in Middle-Aged Men and Women (Calm): Feasibility Randomized Controlled Trial
by: Breanne Laird, et al.
Published: (2022-05-01) -
Insomnia as an Unmet Need in Patients With Chronic Hematological Cancer: Protocol for a Randomized Controlled Trial Evaluating a Consumer-Based Meditation App for Treatment of Sleep Disturbance
by: Jennifer Huberty, et al.
Published: (2022-07-01) -
Cancer Patients’ and Survivors’ Perceptions of the Calm App: Cross-Sectional Descriptive Study
by: Huberty, Jennifer, et al.
Published: (2020-02-01)